Short Interest in Aditxt, Inc. (NASDAQ:ADTX) Increases By 81.5%

Aditxt, Inc. (NASDAQ:ADTX) was the target of a significant increase in short interest during the month of July. As of July 31st, there was short interest totalling 399,400 shares, an increase of 81.5% from the July 15th total of 220,000 shares. Approximately 13.0% of the company’s shares are short sold. Based on an average trading volume of 2,310,000 shares, the short-interest ratio is currently 0.2 days.

Aditxt Stock Performance

Shares of ADTX stock opened at $1.11 on Wednesday. The company has a 50 day moving average price of $1.49 and a 200 day moving average price of $2.46. Aditxt has a fifty-two week low of $0.89 and a fifty-two week high of $68.08.

Aditxt (NASDAQ:ADTX) last issued its quarterly earnings results on Monday, May 20th. The company reported ($9.14) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($3.33) by ($5.81). Aditxt had a negative return on equity of 927.61% and a negative net margin of 5,016.31%.

About Aditxt

Aditxt, Inc, a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. The company develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its own tissues.